ms JAKARA EASON

Issues related to ADHD diagnosis and treatment.

Advocate for access to affordable therapies and technology, including legislative efforts to reduce the cost of insulin.

Funding for programs and research relevant for people with diabetes.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes, issues related to patient access under the proposed GUARD model.

Issues related to ADHD diagnosis and treatment.

Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.

Policy discussions and education related to appropriate use of ADHD treatment.

Policy discussions and education related to appropriate use of ADHD treatment.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.

Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.

Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.

Policy discussions and education related to appropriate use of ADHD treatment.

Policy discussions and education related to appropriate use of ADHD treatment.

Policy activities related to treatment of ADHD.

Policy activities related to treatment of ADHD.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Legislation and other proposed policy change impacting S Corporation ESOPs.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.

Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.

Policy activities related to treatment of ADHD.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act, and measures to prevent amputation.

Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.

ADHD treatment initiatives and policy

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.

Funding for programs and research relevant for people with diabetes.

Advocate for access to affordable therapies and technology.

Educating offices about paper labeling in FDA appropriations.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.

Funding for programs and research relevant for people with diabetes.

Advocate for access to affordable therapies and technology.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.

Educating offices about paper labeling in FDA appropriations.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Legislation and other proposed policy change impacting S Corporation ESOPs.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.

Funding for programs and research relevant for people with diabetes.

Educating offices about paper labeling in FDA appropriations.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Funding for programs and research relevant for people with diabetes.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Funding for programs and research relevant for people with diabetes.

Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.

Promoting access to healthy food for people with diabetes & pre-diabetes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Legislation and other proposed policy change impacting S Corporation ESOPs.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.

Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.